BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8420279)

  • 1. Role of endogenous prostaglandins in secretin- and plaunotol-induced inhibition of gastric acid secretion in the rat.
    Shiratori K; Watanabe S; Takeuchi T
    Am J Gastroenterol; 1993 Jan; 88(1):84-9. PubMed ID: 8420279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gastric mucosal prostaglandin E2 in the inhibitory action of secretin and somatostatin on gastric acid secretion in the rat.
    Shiratori K; Watanabe S; Takeuchi T
    Digestion; 1993; 54(3):163-7. PubMed ID: 8103008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretin as a potential mediator of antiulcer actions of mucosal protective agents.
    Takeuchi T; Shiratori K; Watanabe S; Chang JH; Moriyoshi Y; Shimizu K
    J Clin Gastroenterol; 1991; 13 Suppl 1():S83-7. PubMed ID: 1940202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaunotol prevents the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
    Ohta Y; Kamiya Y; Imai Y; Arisawa T; Nakano H
    Pharmacology; 2005 Jul; 74(4):182-92. PubMed ID: 15855831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of inhibitory action of secretin on gastric acid secretion in conscious rats.
    Shimizu K; Li P; Lee KY; Chang TM; Chey WY
    J Physiol; 1995 Oct; 488 ( Pt 2)(Pt 2):501-8. PubMed ID: 8568688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaunotol stimulates endogenous secretin release and exocrine pancreatic secretion in rats.
    Chang JH; Watanabe S; Shiratori K; Moriyoshi Y; Takeuchi T
    Digestion; 1989; 44(3):142-7. PubMed ID: 2483390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibitory mechanism of secretin action on acid secretion in totally isolated, vascularly perfused rat stomach.
    Chung I; Li P; Lee K; Chang T; Chey WY
    Gastroenterology; 1994 Dec; 107(6):1751-8. PubMed ID: 7958688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of oleic acid-induced inhibition on gastric acid secretion in rats.
    Rhee JC; Chang TM; Lee KY; Jo YH; Chey WY
    Am J Physiol; 1991 Apr; 260(4 Pt 1):G564-70. PubMed ID: 2018132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duodenal acidification and secretin, but not intraduodenal fat, inhibit human gastric acid secretion via prostaglandins.
    Taylor SD; Soudah HC; Chey WY; Scheiman JM
    Gastroenterology; 1994 Dec; 107(6):1680-5. PubMed ID: 7958679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaunotol inhibits postprandial gastrin release by its unique secretin-releasing action in humans.
    Shiratori K; Watanabe S; Takeuchi T; Shimizu K
    Dig Dis Sci; 1990 Sep; 35(9):1140-5. PubMed ID: 2390929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (2E,6Z,10E)-7-hydroxymethyl-3,11,15-trimethyl-2,6,10,14-hexadecatetraen-1-ol (Plaunotol) increases cyclooxygenase-2 expression via nuclear factor kappaB and cyclic AMP response element in rat gastric epithelial cells.
    Fu Hy; Yabe Y; Asahi K; Hayashi Y; Murata H; Eguchi H; Tsujii M; Tsuji S; Kawano S
    Eur J Pharmacol; 2005 Nov; 524(1-3):38-43. PubMed ID: 16253229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of endogenous prostaglandins on secretin-mediated inhibition of gastric acid secretion in dogs.
    MacLellan DG; Upp JR; Thompson JC
    Gastroenterology; 1988 Sep; 95(3):625-9. PubMed ID: 3270330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of plaunotol on release of plasma secretin and pancreatic exocrine secretion in humans.
    Shiratori K; Watanabe S; Takeuchi T; Chang JH; Moriyoshi Y
    Pancreas; 1989; 4(3):323-8. PubMed ID: 2471968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of indomethacin on gastric acid and bicarbonate secretion in humans.
    Feldman M; Colturi TJ
    Gastroenterology; 1984 Dec; 87(6):1339-43. PubMed ID: 6149164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous secretin in the rat--evidence for a role as an enterogastrone but failure to influence serum calcium homeostasis.
    Stollmaier W; Schwille PO
    Exp Clin Endocrinol; 1992; 99(3):169-74. PubMed ID: 1388122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endogenous secretin and cholecystokinin in intraduodenal oleic acid-induced inhibition of gastric acid secretion in rats.
    Shiratori K; Watanabe S; Takeuchi T
    Dig Dis Sci; 1992 Mar; 37(3):397-402. PubMed ID: 1735364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of prostaglandin production by (2E,6Z,10E)-7-hydroxymethyl-3,11,15-trimethyl-2,6,10,14-++ +hexadecatetrae n-1-ol (plaunotol), a new anti-ulcer drug, in vitro and in vivo.
    Ushiyama S; Matsuda K; Asai F; Yamazaki M
    Biochem Pharmacol; 1987 Feb; 36(3):369-75. PubMed ID: 3101705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of gastric acid secretion in rat stomach by PACAP is mediated by secretin, somatostatin, and PGE(2).
    Li P; Chang TM; Coy D; Chey WY
    Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G121-7. PubMed ID: 10644570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sucralfate protection of the gastric mucosa against ethanol-induced injury: a prostaglandin-mediated process?
    Hollander D; Tarnawski A; Gergely H; Zipser RD
    Scand J Gastroenterol Suppl; 1984; 101():97-102. PubMed ID: 6599542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in alkaline secretion during duodenal ulceration induced by mepirizole in rats.
    Tabata K; Jacobson ED; Chen MH; Murphy RF; Joffe SN
    Gastroenterology; 1984 Aug; 87(2):396-401. PubMed ID: 6735082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.